ArticleDisease markers2021

Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response.

Hongye Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.